Abstract
In desperate circumstances, people look for hope. In situations like the confrontation of an Alzheimer's diagnosis for a loved one, families seek answers from health care providers. Multinational pharmaceutical corporations readily step into this space, developing products that can potentially offer hope, at a steep price, to patients and families. In the last 18 to 24 months, several new and novel treatments have achieved a lot of coverage, both in the lay media and in medical journals and meetings.
Publisher
American Society of Consultant Pharmacists
Reference3 articles.
1. US trends in premature heart disease mortality over the past 50 years: where do we go from here?;Trends Cardiovasc Med.,2020
2. Forecasting the global burden of Alzheimer’s disease.;Alzheim Dement.,2007
3. Why physicians should not prescribe aducanumab for Alzheimer disease.;Am Fam Phys J.,2022